Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)
NCT04817046 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 467
Last updated 2021-03-25
Summary
The purpose of this study is to develop a lung cancer diagnosis tool using a multi-omics approach based on liquid biopsy.
Conditions
Sponsors & Collaborators
-
Peking University People's Hospital
lead OTHER
Principal Investigators
-
Fan Yang, MD · Peking University People's Hospital
Eligibility
- Min Age
- 40 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-19
- Primary Completion
- 2022-12-31
- Completion
- 2024-12-31
Countries
- China
Study Locations
More Related Trials
-
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
NCT05742204 ·Status: ACTIVE_NOT_RECRUITING
-
To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer
NCT05432128 ·Status: RECRUITING
-
Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China
NCT01928836 ·Status: COMPLETED
-
Detection of Lung Cancer by Plasma Lipids
NCT04287712 ·Status: COMPLETED
-
Detecting Lung Cancer Based on Exhaled Breath
NCT04419207 ·Status: COMPLETED
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING
-
Dynamic Monitoring Circulating Tumor DNA in Surgical Patients With Lung Cancer
NCT03317080 ·Status: UNKNOWN
-
AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy
NCT07009769 ·Status: COMPLETED
-
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer
NCT03492801 ·Status: TERMINATED
-
Whether Sputum Can Serve as an Alternative Source for Liquid Biopsy in Patients With Lung Cancer
NCT05034445 ·Status: COMPLETED
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study
NCT02907606 ·Status: UNKNOWN
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.
NCT03073902 ·Status: COMPLETED
-
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003 ·Status: UNKNOWN ·Phase: NA
-
Lung EpiCheck Biomarkers Development Study
NCT06245876 ·Status: RECRUITING
-
Fluid Biopsy for the Diagnosis of Lung Cancer
NCT04162678 ·Status: TERMINATED
-
Accelerating Lung Cancer Diagnosis Through Liquid Biopsy
NCT04863924 ·Status: ACTIVE_NOT_RECRUITING
-
Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites
NCT04474613 ·Status: TERMINATED ·Phase: NA
-
Biomarker Discovery in Lung Cancer - Malaysia
NCT06504927 ·Status: RECRUITING
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
NCT04566432 ·Status: RECRUITING
-
Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates
NCT01630122 ·Status: COMPLETED
-
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
NCT03721120 ·Status: COMPLETED ·Phase: NA
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED